Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multifactorial modeling, drug interactions, liver damage and aging.

W D Wosilait1, R H Luecke

  • 1Department of Pharmacology, University of Missouri-Columbia 65212.

General Pharmacology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of methylmercury disposition in humans utilizing a PBPK model and animal pharmacokinetic data.

Journal of toxicology and environmental health. Part A·2001
Same author

Mathematical modeling of human embryonic and fetal growth rates.

Growth, development, and aging : GDA·2000
Same author

Physiological "constants" for PBPK models for pregnancy.

Journal of toxicology and environmental health·1997
Same author

A computer model and program for xenobiotic disposition during pregnancy.

Computer methods and programs in biomedicine·1997
Same author

Mathematical analysis for teratogenic sensitivity.

Teratology·1997
Same author

Mathematical representation of organ growth in the human embryo/fetus.

International journal of bio-medical computing·1995
Same journal

Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin.

General pharmacology·2002
Same journal

Reversal of hypercapnia induces endothelin-dependent constriction of basilar artery in rabbits with acute metabolic alkalosis.

General pharmacology·2002
Same journal

Reversal of hypercapnia induces KATP channel and NO-independent constriction of basilar artery in rabbits with acute metabolic alkalosis.

General pharmacology·2002
Same journal

Contractile responses in spontaneously diabetic mice. II. Effect of cholestyramine on enhanced contractile response of aorta to norepinephrine in C57BL/KsJ (db/db) mice.

General pharmacology·2002
Same journal

Contractile responses in spontaneously diabetic mice. I. Involvement of superoxide anion in enhanced contractile response of aorta to norepinephrine in C57BL/KsJ(db/db) mice.

General pharmacology·2002
Same journal

Investigation of basal endothelial function in the obese Zucker rat in vitro.

General pharmacology·2002
See all related articles

Physiological flow models analyze drug elimination and can guide complex drug therapy in patients with organ dysfunction. Further research is needed to develop a general model for clinical use.

Area of Science:

  • Pharmacokinetics
  • Physiological modeling
  • Drug metabolism

Background:

  • Physiological flow models integrate anatomical and biochemical data to predict drug behavior.
  • These models are crucial for understanding drug distribution, toxicity, and elimination in various organs.
  • Current models exist for specific drug systems but a general, comprehensive model is lacking.

Purpose of the Study:

  • To highlight the utility of physiological flow models in drug therapy analysis.
  • To emphasize their role in managing patients with multiple organ dysfunction.
  • To discuss the potential for multifactorial analysis in rational drug therapy.

Main Methods:

  • Utilizing existing knowledge of anatomy and physiology.
  • Incorporating biochemical pathways of drug elimination.

Related Experiment Videos

  • Calculating drug concentration-vs-time profiles in different tissues and organs.

    • Main Results:

    • Physiological flow models can accurately describe drug concentration profiles for specific systems.
    • They provide a rational basis for multiple drug therapy in high-risk patients.
    • Models can be adapted to include organs critical for drug storage, toxicity, or elimination.

    Conclusions:

    • Physiological flow models are powerful tools for analyzing drug elimination and therapy.
    • They offer a rational approach to managing complex drug regimens in patients with altered organ function.
    • Future research aims to develop a general model for broader clinical application in rational drug therapy.